China Universal Asset Management Co., Ltd. 89bio, Inc. Transaction History
China Universal Asset Management Co., Ltd.
- $893 Million
- Q3 2024
A detailed history of China Universal Asset Management Co., Ltd. transactions in 89bio, Inc. stock. As of the latest transaction made, China Universal Asset Management Co., Ltd. holds 20,370 shares of ETNB stock, worth $179,663. This represents 0.02% of its overall portfolio holdings.
Number of Shares
20,370
Previous 11,560
76.21%
Holding current value
$179,663
Previous $92,000
63.04%
% of portfolio
0.02%
Previous 0.01%
Shares
14 transactions
Others Institutions Holding ETNB
# of Institutions
158Shares Held
108MCall Options Held
73.6KPut Options Held
1.19M-
Janus Henderson Group PLC London, X015.2MShares$134 Million0.06% of portfolio
-
Ra Capital Management, L.P. Boston, MA14.2MShares$125 Million1.46% of portfolio
-
Suvretta Capital Management, LLC New York, NY7.99MShares$70.5 Million2.33% of portfolio
-
Rtw Investments, LP New York, NY7.38MShares$65.1 Million0.87% of portfolio
-
Black Rock Inc. New York, NY7.02MShares$61.9 Million0.0% of portfolio
About 89bio, Inc.
- Ticker ETNB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,484,500
- Market Cap $410M
- Description
- 89bio, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapies for the treatment of liver and cardio-metabolic diseases. Its lead product candidate is pegozafermin, a glycoPEGylated analog of fibroblast growth factor 21 for the treatment of nonalcoholic steatohepatitis. The company also int...